Will US Covid vaccine patent waiver lead to more jabs in India? Not really
3 years, 7 months ago

Will US Covid vaccine patent waiver lead to more jabs in India? Not really

Hindustan Times  

Maya Johal, a 29-year-old schoolteacher in Delhi, booked herself for a coronavirus vaccine shot a week ago, but is still awaiting her turn. “For example, the underlying technology used to develop a vaccine can be protected by patents, while manufacturing methods and techniques can be protected by trade secrets,” wrote authors Mario Gaviria and Burcu Kilic in the first analysis of mNRA vaccine patents in the journal Nature published on May 12, 2021. In their paper, “A network analysis of Covid-19 mRNA vaccine patents”, Gaviria and Kilic explain that this vaccine platform uses multiple technologies, including the main mRNA technology, lipid nanoparticle technology and a delivery-system. Pointing to a complex web, the researchers noted: “However, the patent numbers are redacted in all the filings, making it difficult to determine which are relevant to the production of Covid-19 vaccines.” India’s advantage and way forward Health experts say one potential solution to end the vaccine shortage — one that the World Health Organization has backed — is a “patent pool” similar to one used to make HIV drugs available to poorer countries in the 1990s. Els Torreele, policy associate at the University College London’s Institute for Innovation and Public Purpose, said India, as a “large economy with abundant capacities for pharmaceutical production including vaccines, is in an excellent position to quickly retool production lines for the manufacturing of a variety of technologies and raw materials needed for the global scale up of Covid-19 vaccines”.

Global India South Africa Vaccines Patent Countries Covid Waiver Vaccine Mrna Moderna Covid Vaccine Wto Patents Bharat Biotech Kilic Gaviria  university  waiver  countries  mrna  jabs  covid  vaccines  patents  covid19  patent  global  vaccine  really  lead  india

History of this topic

Global Pandemic Threat: 100 Days to Save Lives
2 months ago

Global Pandemic Threat: 100 Days to Save Lives

Hindustan Times  

A modelling study suggests that if a vaccine for SARS-CoV-2 had been developed within 100 days, an estimated 8.3 million deaths could have been averted globally. The study also estimated that productivity losses due to illness amounting to almost $1.4 trillion and $63 billion of hospitalisation costs would have been averted globally.

ICMR ties up with IIL to develop jab against Zika virus
3 months, 1 week ago

ICMR ties up with IIL to develop jab against Zika virus

Hindustan Times  

The Indian Council of Medical Research has started work on a vaccine against the Zika virus, in collaboration with vaccine manufacturer Indian Immunologicals Limited, people familiar with the matter said. IIL has signed a memorandum of association with ICMR for the clinical development of the vaccine — the country’s first codon de-optimised live attenuated vaccine against Zika — and Phase …

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

New push for mRNA bird flu vaccine development: WHO
4 months, 3 weeks ago

New push for mRNA bird flu vaccine development: WHO

The Hindu  

The World Health Organisation announced Monday, July 29, 2024, a new project to accelerate the development in poorer countries, of vaccines for human bird flu infections, using cutting-edge messenger RNA technology. Vaccine equity Swiftly developed mRNA Covid vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to …

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR
6 months ago

Patent filings credit Bharat Biotech as ‘inventor’ of Covaxin, omit ICMR

The Hindu  

India’s first indigenously developed coronavirus vaccine, Covaxin, was a joint collaboration between the Indian Council of Medical Research and the Hyderabad-based Bharat Biotech International Limited with intellectual property rights jointly shared between the two organisations. The Minister’s statement said the ICMR would provide a “well characterised” virus strain for vaccine development, the BBIL would develop the final vaccine formulation and, …

Vaccinating India: Triumphs and Challenges on the Road to Full Coverage
6 months ago

Vaccinating India: Triumphs and Challenges on the Road to Full Coverage

News 18  

Vaccines have come a long way since Dr Edward Jenner first inoculated an eight-year-old boy against smallpox in 1796. Since 1974, the EPI has boosted global newborn immunisation coverage against DTP from 5 per cent to 84 per cent in India. This program aims to reach every child and pregnant woman who missed routine immunisation due to the Covid pandemic, …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
7 months, 2 weeks ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine
7 months, 3 weeks ago

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

Hindustan Times  

Amid reports over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, Bharat Biotech, which developed the Covaxin, said in a statement that the vaccine was developed with a "single-minded focus on safety first." It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India. "@bharatbiotech announcement - …

India did better than developed countries in vaccination against COVID-19, says Soumya Swaminathan
10 months, 1 week ago

India did better than developed countries in vaccination against COVID-19, says Soumya Swaminathan

The Hindu  

India did much better than even the developed countries when it came to vaccination to prevent the spread of COVID-19, said Soumya Swaminathan, Chairperson of the M.S. She was delivering the Jerome D’Souza memorial endowment lecture on ‘Future Pandemic Prevention in Relation to WHO Experience’, which was jointly organised by Surana and Surana International Attorneys and Loyola College in Chennai …

With State prod, India can be world leader in vaccines
10 months, 4 weeks ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

Serum Institute of India joins global network to boost production of affordable outbreak vaccines
11 months ago

Serum Institute of India joins global network to boost production of affordable outbreak vaccines

The Hindu  

The Serum Institute of India will join a growing CEPI network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future disease outbreaks. The addition of SII to the CEPI manufacturing network will be a significant boost to vaccine production efforts in Global South regions, and take it a step closer to achieving …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
11 months, 4 weeks ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

Accelerating Routine Immunization in India: Insights from Covid-19 Drive
1 year, 1 month ago

Accelerating Routine Immunization in India: Insights from Covid-19 Drive

The Quint  

In the aftermath of Covid-19 pandemic and ensuing vaccination drive in India, the country's healthcare system gained invaluable insights into strengthening routine immunization programs. Learnings for Health Sector: The drive provided crucial insights into routine immunization systems, leveraging existing infrastructure and expertise effectively. Role of MOMENTUM Routine Immunization Transformation & Equity Project: National Roll-Out Support: Initiated in August 2021, the …

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18
1 year, 2 months ago

How India’s Vaccine Industry Will Save Millions of Children in Africa - News18

News 18  

On 2 October 2023, when India celebrated both Gandhi and Lal Bahadur Shastri Jayanti, there was one more reason to celebrate this year. In April 2023, almost coinciding with World Malaria Day, the West African nation Ghana approved the malaria vaccine R21, even before it was approved by the WHO. The vaccine R21 is developed at the University of Oxford …

How a Big Pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits
1 year, 2 months ago

How a Big Pharma company stalled a potentially lifesaving vaccine in pursuit of bigger profits

Salon  

ProPublica is a Pulitzer Prize-winning investigative newsroom. GSK signed on, asking Reed to add the company's promising new adjuvant to his idea for a TB vaccine. And the company only had enough for its other vaccines, so whoever took over the TB vaccine's development would need to pay GSK to ramp up production, which Breuer estimated would cost around $200 …

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine
1 year, 2 months ago

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine

Op India  

Recalling the dreadful chapters from the year 2020 when the spread of novel coronavirus in India killed several lives, affected many businesses, and derailed the normal routine lives of almost all is difficult. But Vivek Ranjan Agnihotri, the marvellous director who earlier amazed audiences with movies like ‘The Kashmir Files’ and ‘The Tashkent Files’ has made an attempt to bring …

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize
1 year, 2 months ago

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize

LA Times  

Dr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19 and that could be used to develop other shots in the future. “This year’s Nobel Prize recognizes their basic science discovery that fundamentally changed our understanding of how mRNA interacts with the immune …

A new TB vaccine could save 8.5m lives over the next quarter of a century
1 year, 5 months ago

A new TB vaccine could save 8.5m lives over the next quarter of a century

The Economist  

Listen to this story. On June 28th two of the world’s wealthiest charities, the Bill & Melinda Gates Foundation and Wellcome, said they would fund a late-stage trial of a new TB vaccine known as M 72. If the new jab really is 50% effective, it could save 8.5m lives, and prevent 76m cases of TB, over the next 25 …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 6 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

Bolster the US-India vaccine collaboration
1 year, 6 months ago

Bolster the US-India vaccine collaboration

Hindustan Times  

As India and the United States look to step up their strategic technology partnership, the former is in an advantageous position in the shifting collaborative paradigm — a confident democracy with a robust and resilient research and development ecosystem. Well supported by globally competitive academic research organisations such as the Indian Council for Medical Research - National Institute of Virology, …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 6 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 6 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?
1 year, 7 months ago

Can a new vaccine rollout change this beaten down pharma MNC's fortune in 2023?

Live Mint  

It's tough being a pharma company these days.the pharma sector, which once used to be the star of the street, has been witnessing bad times since 2022. Over the last few years, the company has underperformed relative to its peers due to a series of challenges, including oncology clinical failures and missing out on the lucrative market for the first …

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report
1 year, 8 months ago

India is 1 of 3 countries where confidence in children’s vaccines has increased: UNICEF report

The Hindu  

Only China, India, and Mexico, that is three out of the 55 countries studied for popular perception of the importance of vaccines for children, showed improvement as per data collected by The Vaccine Confidence Project and published by UNICEF on April 20. UNICEF India today released the agency’s global flagship report ‘The State of the World’s Children 2023: For Every …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 8 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 8 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 8 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns
1 year, 8 months ago

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns

News 18  

Similar to flu shots, India may need to update its Covid-19 boosters with the latest strain of the coronavirus, former director of All India Institute of Medical Sciences, Dr Randeep Guleria told News18.com. A renowned pulmonologist, Dr Guleria said the vaccines in India are currently using the Wuhan strain or the strain which was circulating in December 2019. “But now, …

Centre no longer to procure Covid vaccines for states
1 year, 8 months ago

Centre no longer to procure Covid vaccines for states

Deccan Chronicle  

HYDERABAD: The Centre will no longer follow its practice of procuring Covid-19 vaccines for the states, health minister T. Harish Rao said on Friday, following a decision taken at a meeting on Covid-19 preparedness headed by Union health minister Dr Mansaukh Mandaviya. Harish Rao, in a press note, said the Union minister had advised state governments to procure vaccines from …

Active COVID-19 cases in India rise to 21,179
1 year, 8 months ago

Active COVID-19 cases in India rise to 21,179

The Hindu  

India logged 3,038 new coronavirus cases, while the active cases increased to 21,179, according to the Union Health Ministry data updated on Tuesday, April 4, 2023. The COVID-19 case tally was recorded at 4.47 crore The active cases now comprise 0.05 per cent of the total infections and the national COVID-19 recovery rate was recorded at 98.76 per cent, the …

India sees a surge in COVID-19 cases: Does the country need a fourth jab?
1 year, 8 months ago

India sees a surge in COVID-19 cases: Does the country need a fourth jab?

Firstpost  

India has registered 3,641 fresh cases of COVID-19 in the last 24 hours. Experts say taking a booster shot may not be very beneficial COVID-19 cases across several states in India are on the rise, thanks to XXB.1.16 – a subtype of Omicron, also a matter of concern. According to the health ministry data, India logged 3,641 new infections in …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 9 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

History TV18's 'The Vial': India's COVID vaccine journey; a true success story
1 year, 9 months ago

History TV18's 'The Vial': India's COVID vaccine journey; a true success story

Firstpost  

When COVID broke out the medical community had no idea how to deal with it. ‘The Vial’ also chronicles the development of the Covishield vaccine — From isolation of the strain at Pune’s National Institute of Virology to manufacturing billions of vials of two of the world’s most effective vaccine candidates in record time to cater to the country’s massive …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 9 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

Covid vaccine mission is a lesson for the world
1 year, 9 months ago

Covid vaccine mission is a lesson for the world

Hindustan Times  

When Covid-19 began in early 2020, most experts predicted India could face disastrous consequences. India’s response to the pandemic highlighted the underlying strengths of our scientific and technological prowess Not only did India succeed in protecting its population, but it also sent vaccines to other countries, thus proving to the world its capability of developing the first-ever DNA vaccine and …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief
1 year, 10 months ago

‘India’s contribution to Covid vaccines has been tremendous’: CEPI chief

Hindustan Times  

Richard Hatchett, CEO of CEPI who is on a visit to India, spoke to HT about the country gaining attention globally by manufacturing and developing anti-Covid vaccines in less than a year, and lessons learnt from the pandemic. Did the fact that India developed and produced Covid vaccines in less than a year catch global attention? And it wasn’t just …

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India
1 year, 10 months ago

Bharat Biotech starts dispatching nasal vaccines: Why it’s a big thing for India

Live Mint  

The world's first intranasal heterologous booster dose has begun to be dispatched by Bharat Biotech to hospitals, Executive Chairman Dr. Krishna Ella announced on February 5. He discussed the delivery of vaccines under the bilateral agreement between the Ella Foundation and the UW-Madison Global Health Institute for the establishment of the first-ever UW-Madison One Health Center in India for improving …

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1
1 year, 10 months ago

Over 7,000 Doses of Bharat Biotech's Intranasal Jab Ready for Market Rollout as Apex Lab Clears Batch 1

News 18  

Over 7,000 doses of the world’s first intranasal Covid-19 vaccine, Bharat Biotech’s iNCOVACC, have been checked and released by the country’s apex vaccine testing laboratory, News18.com has learnt. BBV154, a novel adenovirus vectored intranasal vaccine for Covid-19, was sent to CDL in the first week of January in around six batches containing 15,000 doses. In polio, the dropper drops the …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

What is nasal vaccine - iNCOVACC? All you need to know
1 year, 10 months ago

What is nasal vaccine - iNCOVACC? All you need to know

India TV News  

Covid19 nasal vaccine : Union Health Minister Mansukh Mandaviya on Friday launched Bharat Biotech's first India-made nasal Vaccine, iNCOVACC, as a booster shot for Covid19. According to Bharat Biotech, the nasal vaccine is likely to prevent infection, thus, preventing the transmission of the virus. The event saw the Union Minister of State Science & Technology; Minister of State Earth Sciences; …

Centre rolls out first nasal Covid vaccine as booster
1 year, 10 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 10 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 11 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Discover Related